Wake Forest University Health Sciences: Infections trials

The registry lists 10 Infections studies with Wake Forest University Health Sciences as lead sponsor. 1 are open to participants now and 3 have results posted.

Phase 4 4No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Intraosseous Antibiotics for OsseointegrationNot yet recruitingNCT07621094Not applicable
• Effects of Intravenous (IV) Omadacycline on Gut MicrobiomeCompletedNCT05515562Phase 4Results posted
• Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic SurgeryCompletedNCT03287089Phase 4Results posted
• Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard CystoscopyCompletedNCT02922868Not applicableResults posted
• Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE InfectionsWithdrawnNCT04785924Phase 4
• COVID-19 IgG Formation in Physicians at ALGH and Their Household MembersCompletedNCT04540484
• Dalbavancin Outpatient PilotWithdrawnNCT03982030Phase 4
• Comparative Effectiveness of Emergency Ultrasound Guided Management of Pediatric Soft Tissue InfectionsCompletedNCT02099227
• Reusable Versus Disposable Draping System in Breast Reconstruction SurgeryCompletedNCT01176786Not applicable
• Risk Assessment of Long-Haul Truck DriversCompletedNCT00381992